KF 19514

inhibits both PDE1 and PDE4

Also Known As:

5-phenyl-3-(3-pyridil)methyl-3H-imidazo(4,5-c)(1,8)naphthyridin-4(5H)-one; KF-19514

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Asthma (Bronchial Asthma) 05/26/1997 - "These results suggest that although both inhibitors of phosphodiesterase III and phosphodiesterase IV have a bronchodilator or bronchoprotective effect, phosphodiesterase IV inhibitors such as KF-19514 may be more useful for asthma treatment because KF-19514 had an anti-allergic effect in addition to the functional bronchodilator activity."

1.	Type 4 Cyclic Nucleotide Phosphodiesterases
2.	Type 3 Cyclic Nucleotide Phosphodiesterases
3.	Anti-Allergic Agents (Antiallergic Agents)
4.	Bronchodilator Agents (Bronchodilators)